Year: 2021
Type: article
Abstract: Studies supporting a strong association between tau deposition and neuronal loss, neurodegeneration, and cognitive decline have heightened the allure of tau and tau-related mechanisms as therapeutic targets. In February 2020, leading tau experts from around the world convened for the first-ever Tau2020 Global Conference in Washington, DC, co-organized and cosponsored by the Rainwater Charitable Foundation, the Alzheimer's Association, and CurePSP. Representing academia, industry, government, and the philanthropic sector, presenters and attendees discussed recent advances and current directions in tau research. The meeting provided a unique opportunity to move tau research forward by fostering global partnerships among academia, industry, and other stakeholders and by providing support for new drug discovery programs, groundbreaking research, and emerging tau researchers. The meeting also provided an opportunity for experts to present critical research-advancing tools and insights that are now rapidly accelerating the pace of tau research.
Source: Alzheimer s & Dementia
DOI: 10.1002/alz.12452
Authors: Claire Sexton, Heather Snyder, Dirk Beher, Adam L. Boxer, Pat Brannelly, Jean‐Pierre Brion, Luc Buée, Angela M. Cacace, Gaël Chételat, Martin Citron, Sarah L. DeVos, Kristophe Diaz, Howard H. Feldman, Bess Frost, Alison M. Goate, Michael Gold, Bradley Hyman, Keith Johnson, Celeste M. Karch, Diana R. Kerwin, Walter J. Koroshetz, Irene Litvan, Huw R. Morris, Catherine J. Mummery, James Mutamba, Marc C. Patterson, Yakeel T. Quiroz, Gil D. Rabinovici, Amy Rommel, Melanie B. Shulman, Leticia M. Toledo‐Sherman, Stacie Weninger, Kristin R. Wildsmith, Susan L. Worley, Maria C. Carrillo
Institutions: Alzheimer's Association, Asceneuron (Switzerland), University of California, San Francisco, Université Libre de Bruxelles, Inserm, Université de Lille, Centre Hospitalier Universitaire de Lille, Lille Neurosciences & Cognition, Arvinas (United States), Cyceron, Physiopathologie et imagerie des troubles neurologiques, Université de Caen Normandie, UCB Pharma (Belgium), Denali Therapeutics (United States), CurePSP, University of California San Diego, The University of Texas at San Antonio Health Science Center, Icahn School of Medicine at Mount Sinai, AbbVie (United States), Harvard University, Massachusetts General Hospital, Washington University in St. Louis, The University of Texas Southwestern Medical Center, National Institute of Neurological Disorders and Stroke, UCL Queen Square Institute of Neurology, University College London, National Hospital for Neurology and Neurosurgery, Mayo Clinic, Rainwater Charitable Foundation, Biogen (United States), Genentech
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,000
OpenAlex ID: W3203796836